SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (7992)5/11/1998 5:45:00 PM
From: Mark A. Stang  Read Replies (4) | Respond to of 23519
 
Scripts Numbers OK

Overall decline for w/e 5/1 is 10%, compared to 17% and 22% for two prior weeks.

New scripts are down 16%, compared to 23.5% and 42.4% declines for two prior weeks.

Refill rate declined 4.3%, down from last w/e 4/24 decline of 10.9%.

I think we're going to break below 10 again this week, at which time I plan to buy more (now holding only 1,000 shares in my IRA).

Anyone with access to non-U.S. sales numbers?



To: VLAD who wrote (7992)5/11/1998 6:28:00 PM
From: DaiS  Read Replies (2) | Respond to of 23519
 
Vlad

Do you have the latest refill numbers for viagra? Also how has caverject stood up this week?

I'm surprised that the new muse scripts have stood up so well.

**Are these men (or docs) who have never heard of viagra!!??

**Are they men who've gone to their doc to be told
"Look buddy in your condition you've no chance getting it up with
viagra, try muse"?

**Are these men trying viagra and muse at the same time?

Did I miss something obvious?

DaiS


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News